About us
Our team
Our science
Radiopharmaceuticals
Our technology
Abstracts & publications
Our pipeline
News
All news
ASX releases
Media releases
Events and presentations
Investors
Share price
Annual reports
Shareholder newsletter
Analyst coverage
Corporate governance
Corporate policies
Contact us
About us
Our team
Our science
Radiopharmaceuticals
Our technology
Abstracts & publications
Our pipeline
News
All news
ASX releases
Media releases
Events and presentations
Investors
Share price
Shareholder newsletter
Analyst coverage
Corporate governance
Corporate policies
Contact us
Investors
annual reportS
September 2023
RAD Annual Report 2023
Download
September 2023
RAD ESG Report 2023
Download
September 2023
RAD Corporate Governance Statement 2023
Download
September 2023
RAD Appendix 4G
Download
Load more
shareholder newsletter
August 2023
Radiopharm Newsletter Jul/Aug 2023
Download
May 2023
Radiopharm Newsletter 1st Quarter 2023
Download
December 2022
Radiopharm Newsletter December 2022
Download
July 2022
Radiopharm Newsletter July 2022
Download
Load more
ANalyst coverage
September 2023
Diamond Equity Research Update Valuation at 70 cents per share
Download
June 2023
Jones Research Update - Price Target 75 cents per share 26 June 2023
Download
June 2023
Diamond Equity Research Update 5 June 2023
Download
June 2023
Bell Potter Research update Valuation at 25 cents per share 1 Jun 2023
Download
Load more
corporate governance
Radiopharm Theranostics Prospectus and Supplementary Disclaimers
Download
Radiopharm Theranostics Prospectus
Download
Radiopharm Theranostics Supplementary Prospectus
Download
Corporate Governance
Download
corporate policies
Privacy Policy
Download
Sign up to our mailing list.
Receive all the latest news from Radiopharm Theranostics.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form. Please fill out all starred fields.
%20.png)
